Midatech Pharma’s OpsiSporin showing ‘exceedingly good promise’ – CEO


Jim Phillips, chief executive of Midatech Pharma (LON:MTPH), says eye-disease drug OpsiSporin is on an accelerated programme in terms of investment priorities after it showed ‘exceedingly good…

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

http://ift.tt/1GSlnuz @MasterMetals MasterMetals Blog

from MasterMetals http://ift.tt/1EPNVmD

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s